MEPERIDINE (DEMEROL) MARKET ANALYSIS

Regional Analysis

Global Meperidine (Demerol) Market - Regional Analysis

Among regions, North America is estimated to hold the dominant position in the global meperidine (Demerol) market over the forecast period. This is due to the increasing number of hysterectomy procedures in the U.S. For instance, according to an article published by Center for Disease Control and Prevention on January 2022, using the data from Behavioral Risk Factor Surveillance System (BRFSS) and National Health Interview Survey (NHIS), an increasing trend in hysterectomy prevalence by age and directional difference by race and ethnicity was observed. It was found that fewer than 2% of women aged 20-29 years and more than four out of 10 women aged 70-79 years reported had hysterectomy. Such surgical procedures need meperidine as an analgesic, which can drive the global meperidine (Demerol) market growth over the forecast period. 

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa